Putative DNMT3A and DNMT3B somatic driver mutations are also widespread in cancer (Figure 3) but the majority of these are uncharacterised with the exception of DNMT3A mutations in acute myeloid leukeamia (AML). This evidence concerns the gene DNMT3A and acute myeloid leukemia.